BioSpace News Archive

Business

Ingenza’s Alison Arnold wins Scottish Women’s Award for scientific achievement

Ingenza is delighted to announce that Alison Arnold – the company’s Head of Fermentation and Microbiology – has won the Scottish Women’s Award 2018 for Services to Science and Technology.

September 19, 2018
·
1 min read
Evonetix makes key appointments to support development of novel gene synthesis technology

EVONETIX LTD announced today that it has expanded its team three-fold, following a successful series A round of £9 million ($12.3M) to support the development of the Company’s technology.

September 19, 2018
·
3 min read
Business

MorphoSys and LEO Pharma Expand Strategic Alliance to Develop Peptide-derived Therapeutics

LEO Pharma A/S and MorphoSys AG today announced an expansion of their existing strategic alliance to include peptide-derived therapeutics.

September 19, 2018
·
6 min read
Biotech Bay

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

September 19, 2018
·
1 min read
Job Trends

Sekisui XenoTech Adds Rodent, Monkey Hepatocytes to Patented CryostaX® Product Line

Company Anticipates the End of Traditionally Cryopreserved Hepatocytes

September 19, 2018
·
4 min read
Drug Development

AstraZeneca’s Asthma Drug Looks Good in Multiple Late-Stage Trials

AstraZeneca released positive results from the BORA Phase III extension clinical trial of Fasenra (benralizumab) as an add-on maintenance therapy in patients with severe eosinophilic asthma that had already completed either the SIROCCO or CALIMA Phase III trials.

September 19, 2018
·
3 min read
·
Mark Terry
Drug Development

Galera Therapeutics Nabs $150 Million to Drive Lead Therapeutic Into Phase III

Privately-held Galera Therapeutics, Inc. secured $150 million in a Series C funding round that will be used to drive its experimental head and neck cancer treatment GC4419 into Phase III trials, as well as support pre-commercialization activities.

September 19, 2018
·
2 min read
·
Alex Keown
Policy

FDA Requests Another Trial for Pharming’s Ruconest Label Expansion

The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL), basically a rejection, to Netherlands-based Pharming Group for its supplemental Biologics License Application (sBLA) for Ruconest.

September 19, 2018
·
2 min read
·
Mark Terry
What About the Team? 3 Ways to Handle the Co-Worker Who’s Always out for Themselves

Whether you consider yourself a team player or just an active contributor, you’ve probably come in contact with someone who is the exact opposite.

September 19, 2018
·
3 min read
·
Porschia Parker
Bedfont announces launch of 2nd generation NObreath® at ERS 2018, Paris

Bedfont Scientific Ltd. launches their new and improved FeNO monitor exclusively at the world’s largest European Respiratory Society Congress with a competition to win one.

September 19, 2018
·
2 min read